SCHEMBL8703769

SCHEMBL8703769

COCNC(=O)C(Cc1c[nH]c2ccccc12)OC(N)=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.50
▸ MAPT P10636 3/20 0.49
▸ POLB P06746 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ KDM4E B2RXH2 2/20 0.49
▸ APAF1 O14727 1/20 0.49
▸ RECQL P46063 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MPO P05164 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ BLM P54132 1/20 0.49
▸ PMP22 Q01453 1/20 0.49
▸ HIF1A Q16665 1/20 0.49
▸ TACR3 P29371 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ ECE1 P42892 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ADRB1 P08588 1/20 0.47
▸ HTR1A P08908 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4132286 0.87 KMT2A (0.54) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL4110000 0.86 KDM4E (0.53) KMT2AMAPTPOLBMEN1KDM4E
Hydrochloric Acid SCHEMBL28371347 0.86 KMT2A (0.53) KMT2AMAPTPOLBMEN1KDM4E
Hydrochloric Acid SCHEMBL28371346 0.86 KMT2A (0.53) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL28371204 0.83 KDM4E (0.50) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL28371206 0.83 KDM4E (0.50) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL27484962 0.81 MAPT (0.59) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL27484963 0.81 MAPT (0.59) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL8483346 0.80 MMP9 (0.63) KMT2AMAPTPOLBMEN1KDM4E
SCHEMBL28435992 0.79 KCNT1 (0.51) KMT2AMAPTPOLBGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5846942-A Cholecystokinin antagonists, their preparation and therapeutic use WARNER-LAMBERT COMPANY (US) 1998-12-08 — — US disclosed
Send feedback